Figure 4.
Results of the LASSO regression analysis and ROC curves for risk factors associated with SJS/TEN related to anticancer therapies. (A) Optimal regularization parameter λ in the LASSO regression model; (B) Evolutionary trajectories of variable coefficients across the λ-spectrum; (C) AUC of the multifactorial logistic regression analysis. LASSO, least absolute shrinkage and selection operator; ROC, receiver operating characteristic; AUC, area under curve; SJS/TEN, Stevens-Johnson syndrome and/or toxic epidermal necrolysis.
